Mechanism of action of IVIG and anti-D in ITP (Q33347843)

26 July 2017

1 reference

title

Mechanism of action of IVIG and anti-D in ITP (English)

1 reference

https://api.crossref.org/works/10.1016/S1473-0502(03)00043-0

29 December 2023

Andrew R Crow

1 reference

26 July 2017

Alan H Lazarus

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12725951

29 December 2023

publication date

1 June 2003

1 reference

full work available at URL

26 July 2017

https://api.elsevier.com/content/article/PII:S1473050203000430?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1473-0502(03)00043-0

https://api.elsevier.com/content/article/PII:S1473050203000430?httpAccept=text/plain

29 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1473-0502(03)00043-0

Transfusion and Apheresis Science

29 December 2023

published in

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

249-255

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Effect of intravenous immunoglobulin in immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Successful response to intravenous immunoglobulin in autoimmune haemolytic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Immune thrombocytopenia and Fc receptor-mediated phagocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Fc-depleted vs intact intravenous immunoglobulin in chronic ITP

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: comparative efficacy of 7S and 5S preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Monoclonal antibody 197 (anti-Fc gamma RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc gamma RI on circulating monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Inhibition of monocyte and polymorphonuclear granulocyte immune phagocytosis by monoclonal antibodies specific for Fc gamma RI, II and III

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

The anti-Fc gamma RIII mAb 3G8 induces neutrophil activation via a cooperative actin of Fc gamma RIIIb and Fc gamma RIIa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Resolution of severe thrombocytopenia in a pregnant patient with rhesus-negative blood with autoimmune thrombocytopenic purpura after intravenous rhesus immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Inhibitory signaling by B cell Fc gamma RIIb

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Immunology. Giving inhibitory receptors a boost

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Autoimmune thrombocytopenia: anti-glycoprotein IIb/IIIa auto antibodies are reduced after human anti-D immunoglobulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Gamma-globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

CD4 and CD8 subpopulation changes during high dose intravenous immunoglobulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Cellular sites of immunologic unresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Immunoglobulin in the control of complement action

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Intravenous immunoglobulins and transforming growth factor β

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900043-0

7 January 2021

Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016/S1473-0502(03)00043-0

Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG

29 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1473-0502(03)00043-0

29 December 2023

Identifiers

1 reference

26 July 2017

1 reference